<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60-jcm-09-02084">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ko</surname>
    <given-names>W.C.</given-names>
   </name>
   <name>
    <surname>Rolain</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>N.Y.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.T.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>P.I.</given-names>
   </name>
   <name>
    <surname>Hsueh</surname>
    <given-names>P.R.</given-names>
   </name>
  </person-group>
  <article-title>Arguments in Favour of Remdesivir for Treating SARS-CoV-2 Infections</article-title>
  <source>Int. J. Antimicrob. Agents</source>
  <year>2020</year>
  <volume>55</volume>
  <fpage>105933</fpage>
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105933</pub-id>
  <pub-id pub-id-type="pmid">32147516</pub-id>
 </element-citation>
</ref>
